The immune system as a target for therapy of SARS-CoV-2: a systematic review of the current immunotherapies for COVID-19

AH Mansourabadi, M Sadeghalvad… - Life sciences, 2020 - Elsevier
Aims The immune response is essential for the control and resolution of viral infections.
Following the outbreak of novel coronavirus disease (COVID-19), several immunotherapies …

Immunobiology and immunotherapy of COVID‐19: A clinically updated overview

A Esmaeilzadeh, R Elahi - Journal of cellular physiology, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a new member of the
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …

COVID-19: immunology, immunopathogenesis and potential therapies

A Bhardwaj, L Sapra, C Saini, Z Azam… - International reviews …, 2022 - Taylor & Francis
Abstract The Coronavirus Disease-2019 (COVID-19) imposed public health emergency and
affected millions of people around the globe. As of January 2021, 100 million confirmed …

Potential therapeutic options for COVID-19: an update on current evidence

Z Niknam, A Jafari, A Golchin, F Danesh Pouya… - European journal of …, 2022 - Springer
Abstract SARS-CoV-2, a novel coronavirus, is the agent responsible for the COVID-19
pandemic and is a major public health concern nowadays. The rapid and global spread of …

Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view

A Kronbichler, M Effenberger, M Eisenhut, KH Lee… - Autoimmunity …, 2020 - Elsevier
Now COVID-19 is causing a severe public health emergency and the mortality is rapidly
increasing all over the world. In the current pandemic era, although there have been many …

The possible of immunotherapy for COVID-19: A systematic review

A AminJafari, S Ghasemi - International immunopharmacology, 2020 - Elsevier
Abstract The novel coronavirus (2019-nCoV) is an emerging pathogen that was first
described in late December 2019 and causes a severe respiratory infection in humans …

Immunotherapy for SARS-CoV-2: potential opportunities

M Pashaei, N Rezaei - Expert opinion on biological therapy, 2020 - Taylor & Francis
Coronavirus Disease 2019 (COVID-19), caused by a novel coronavirus, called Severe Acute
Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), emerged at the end of 2019 in Wuhan …

Diverse immunological factors influencing pathogenesis in patients with COVID-19: a review on viral dissemination, immunotherapeutic options to counter cytokine …

AA Rabaan, SH Al-Ahmed, MA Garout, AM Al-Qaaneh… - Pathogens, 2021 - mdpi.com
The pathogenesis of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is still not fully unraveled. Though …

Immune reactivity during COVID-19: Implications for treatment

C Napoli, G Benincasa, C Criscuolo, M Faenza… - Immunology letters, 2021 - Elsevier
Clinical symptoms of COVID-19 include fever, cough, and fatigue which may progress to
acute respiratory distress syndrome (ARDS). The main hematological laboratory findings …

Immune responses in mildly versus critically ill COVID-19 patients

H Nasrollahi, AG Talepoor, Z Saleh… - Frontiers in …, 2023 - frontiersin.org
The current coronavirus pandemic (COVID-19), caused by SARS-CoV-2, has had
devastating effects on the global health and economic system. The cellular and molecular …